Introduction
Cervical cancer (CESC) is one of the leading etiologies of malignant tumor deaths in woman aged 20-39 years. According to the National Center for Health Statistics, in 2017, there were 12,820 estimated new cases of CESC and 4,210 estimated deaths caused by CESC in America. 1 In fact, CESC deaths in developing countries account for 90% of the world's total death toll, causing severe public health problems and financial burden. 2 Some studies have shown that miRNAs are associated with the development and prognosis of CESC. [3] [4] [5] Previous studies have reported that lymph node metastasis (LNM) in early-stage CESC influences the patient's survival and outcomes of subsequent adjuvant therapy, but there is limited research on the relationship between LNM and miRNAs in early-stage CESC. [6] [7] [8] [9] Therefore, it is meaningful to study the molecular mechanisms of CESC and identify miRNA markers for individualized treatment plans and prognostic prediction of CESC.
miRNA expression data analyses
The miRNA expression analyses were performed using the "edgeR" package in R. 24 From a total of 1,046 miRNAs, 422 miRNAs were detected in at least two cohorts, and miRNAs with no ID on miRBase21 or with a mean expression <3 raw counts were removed. Each individual miRNA was log2-transformed for further analysis. All DEGs were considered significant if the absolute fold changes were more than 1.5 and the P-value was <0.05.
Prediction of miRNA target genes
To date, miRWalk2.0 is the only comprehensive archive that can be accessed for free, providing the largest available predictive and experimental miRNA-target interaction data and offering novel and unique features. 25 Target genes of three miRNAs were predicted based on the miRWalk database, and overlapped genes among the miRanda, PITA, and Targetscan databases were selected. A P-value<0.05 represented statistical significance.
GO, KEGG, and PPI network analyses
Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses are the common methods for studying the functions and pathways associated with large-scale genome data or transcriptional data. GO and KEGG enrichment analyses were performed using BiNGO 3.0.3 and DAVID 6.8. 26, 27 The protein-protein interaction (PPI) networks were analyzed through the STRING 10.5 database and Molecular Complex Detection (MCODE) 1.5.1. 28, 29 The network was further visualized using Cytoscape 3.6.1. 30 
Statistical analyses
The data are shown as the mean ± SD or as the median. Chi-square tests were used to assess differences in race, tumor grade, and tumor status between the LNM(+) and LNM(−) cohorts. Other data, such as age and smoking history, were evaluated using independent-sample t-tests. Kaplan-Meier survival analyses and univariate and multivariate Cox proportional risk regression analyses were conducted to compare miRNA levels (high-and low-expression levels) and prognosis.
The data were analyzed using GraphPad Prism 5.0 (La Jolla, CA, USA) and R software, and a P-value <0.05 was considered statistically significant.
Results

The effect of lymph node status on the survival of CESC patients
This study involved 145 patients with early-stage CESC, including 32 LNM(+) patients and 113 LNM(−) patients. The clinical data of these patients are presented in Table 1 . Indeed, there were no significant differences in age, race, smoking history, or tumor grade between the LNM(+) and LNM(−) patients. Survival analysis showed that the survival time of the LNM(+) group was shorter than that of the LNM(−) group (P<0.05; Figure 1 ). 
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Comprehensive miRNA profiles of early-stage CESC were generated for LNM(+) and LNM(−) patients. In total, 75 miRNAs were differentially regulated and had a P-value <0.05 and an absolute fold change of more than 1.5 (Supplementary  table S1 ). As shown in Figure 2 , of these 75 miRNAs, 24 miRNAs (32.0%) were downregulated in LNM(+) patients, while the remaining 51 (68.0%) miRNAs were upregulated in LNM(+) patients. Seventy-five miRNAs were selected for further analyses.
Identification of miRNAs correlated with the survival of CESC patients
To identify the association between miRNAs and the survival of CESC patients, the overall survival times of 275 CESC patients in the TCGA dataset were analyzed by the Kaplan-Meier method and log-rank tests. The results showed that patients with high hsa-miR-508 or hsa-miR-526b levels had a longer overall survival time than did those with low hsa-miR-508 level or hsa-miR526b levels (log-rank test: P=0.006, 0.003), as shown in Figure 3 . The correlation of hsa-miR-509-2 level with overall survival time in the 275 CESC patients was not significant. The miRNA expression data are shown in Figure 4 and Table 2 .
Univariate and multivariate Cox regression analyses in CESC patients
The clinical features of age, smoking history, clinical stage, tumor grade, and metastasis were considered in the uni- (Table 3) .
Functional implication of prognostic miRNA signatures
To further analyze the mechanisms of these miRNAs (hsamiR-508, hsa-miR-509-2, and hsa-miR-526b) in CESC, we used miRWalk2.0, which identifies overlapping genes between miRanda, PITA, and the Targetscan databases to predict target genes. Then, we performed functional enrichment analysis with GO and KEGG using BiNGO and DAVID. The GO BP terms were remarkably enriched in epithelial cell development, regulation of cell shape, neuronal migration, and so on. For the GO cellular component (CC) terms, the target genes were concentrated in the cortical actin cytoskeleton, postsynaptic density, and so on. The molecular function (MF) category was focused on steroid hormone receptor activity, NOTCH binding, and so on ( Figure 5 , Table  4 ). In addition, the KEGG pathways were mostly enriched in cancer pathways, including the MAPK, cAMP, PI3K/Akt, mTOR, and estrogen signaling pathways ( Figure 6 , Table 5 ).
The GO network was illustrated as an interaction network using the Cytoscape plug-in BiNGO, which maps the main functional categories of a given gene set in the GO hierarchy. As shown in Figure 7 , the regulation of cellular and primary metabolic processes was important in the BP network. In the CC network, the cell and intracellular components were in core positions ( Figure 8 ). Additionally, the ion, cation, metal ion, and zinc ion binding components were significant in the MF network ( Figure 9 ).
Selection of hub proteins
The PPI network of target genes was analyzed according to the STRING database, including 956 nodes and 3,448 edges. Then, we used the MCODE plug-in in Cytoscape software to build the core module, which consist of 29 nodes and 95 edges (MCODE score: 7.000). The highly connected node with the highest height is considered the hub protein of the network. A total of 29 proteins were selected as the most significant hub proteins, including TP53 (a target of hsamiR-508, hsa-miR-509-2, and hsa-miR-526b), MMP1 (a target of hsa-miR-509-2 and hsa-miR-526b), NOTCH1 (a target of hsa-miR-509-2), SMAD4 (a target of hsa-miR-508 
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Differentially expressed miRNAs in early-stage CESC and hsa-miR-526b), and NFKB1 (a target of hsa-miR-508), which might be associated with LNM in early-stage CESC ( Figure 10 ).
Discussion
CESC is one of the major primary gynecological tumors that affect women's health. In developing countries, the 5-year overall survival rate is only 46%, which is far lower than that of developed countries. 2 LNM in the early stage affects the prognosis of CESC. 6 Therefore, it is necessary to identify prognostic miRNAs and determine their molecular mechanisms. In this study, we found that hsa-miR-508, hsamiR-509-2, and hsa-miR-526b were downregulated in LNM(+) patients and could effectively evaluate the prognosis of CESC. Moreover, we explained the potential mechanisms via GO and KEGG enrichment and PPI network analyses of target genes.
As far as we know, there is limited research on the role of these three miRNAs (hsa-miR-508, hsa-miR-509-2, and hsa-miR-526b) in CESC. We first demonstrated that three miRNAs were downregulated in early-stage CESC LNM(+) patients and influenced the prognosis of CESC through bioinformatics analysis. In a recent study, Liu et al reported that hsa-miR-508 is an independent, protective prognostic factor of glioma, and functional tests confirmed that overexpression of hsa-miR-508 inhibits the migration of glioma cells, which was similar to the results of our study. 31 In gastric cancer, hsa-miR-508 inhibits the invasion of gastric cancer cells by targeting S-phase kinase-associated protein 2. 32 Huang et al also found that hsa-miR-508 expression is downregulated in gastric carcinogenesis cell lines and plays a major role as a tumor suppressor gene in gastric cancer. 33 Moreover, miRNA microarray profiling showed that hsa-miR-508 expression is downregulated in lymph node metastatic tissues. 34 In addition, Zhai et al indicated that hsa-miR-508 inhibits renal cell cancer cell invasion and migration. 35 hsa-miR-509 serves as a cancer suppressor gene in various cancers, such as lung cancer, breast cancer, renal cell cancer, and pancreatic cancer. [36] [37] [38] [39] [40] hsa-miR-509 can inhibit tumor cell invasion and migration through target genes. Using bioinformatics analysis, hsa-miR-509 was found to be downregulated in breast cancer and brain metastasis compared to primary cancer and was shown to play a role in suppressing brain metastasis by regulating the RhoC-TNF-α network in both in vivo and in vitro experiments. 41 Additionally, low expression levels of hsa-miR-509 were associated with poor outcomes in pancreatic cancer patients. 39 hsa-miR-526b can inhibit tumor progression by targeting MMP1. 42 Meanwhile, Zhang et al found that hsa-miR-526b is downregulated in lung cancer, and low expression was associated with poor clinical outcomes through the p53/p21 pathway. 43 In colon cancer, hsa-miR-526b was reported to be downregulated in metastatic tissue and to inhibit cell proliferation and invasion by regulating the hub gene HIF-1α. 44 Liu et al observed that low hsa-miR-526b expression correlates with poor prognosis in hepatocellular carcinoma and enhanced lung metastasis in mouse lungs via the ERK pathway. 
Notes:
The MCODE was conducted to screen modules of the PPI network with a degree cutoff =2, node score cutoff =0.2, k-core =2, and maximum depth =100. Abbreviation: PPI, protein-protein interaction.
To investigate the mechanism of LNM in early-stage CESC, we conducted KEGG pathway and GO annotation enrichment analyses and PPI network analyses on three miRNA target genes. Pathway enrichment analysis showed that the target genes were mainly enriched in pathways in cancer, such as MAPK, cAMP, PI3K/Akt, and mTOR pathways. The MAPK pathway has been reported to play a role in the tumor progression of CESC. 13, 46, 47 Zhang et al found that the MAPK pathway was associated with LNM in head and neck cancer. 48 Research has shown that the Akt/ mTOR pathway is activated in medullary thyroid carcinoma with lymph node metastases. 49 In the coexpression regulatory network of target genes, multiple studies have shown that a TP53 gene mutation increases the risk of CESC. [50] [51] [52] MMP1 has been associated with LNM in esophageal squamous cell cancer, 53 lung cancer, 54 and gastric cancer. 55 Liu et al reported that MMP1 promotes esophageal squamous cell carcinoma cell migration and invasion via the PI3K/ Akt pathway. 53 In CESC, NOTCH1 has been associated 
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Differentially expressed miRNAs in early-stage CESC with LNM, and high expression of NOTCH1 indicates a poor prognosis in patients. 56 At the same time, Park et al found that NOTCH1 could be a molecular marker of LNM in papillary thyroid cancer. 57 In pancreatic and colorectal cancer, SMAD4 was found to be associated with LNM and survival. 58, 59 Another gene in the network, NFKB1, was reported to increase the risk of LNM in gastric cancer and oral cancer. 60, 61 These results suggest that the target genes of these three miRNAs play a significant role in LNM in early-stage CESC.
However, there are some deficiencies in our research at present. Although the three miRNAs were downregulated in LNM(+) patients according to the bioinformatics analyses, the original samples need additional validation. Functional tests need to be conducted, and the mechanism of LNM in early-stage CESC needs further study. Our group is currently pursuing some of these research goals.
Conclusion
Using bioinformatics analysis, we have shown for the first time that three miRNAs were downregulated in early-stage CESC LNM(+) patients and are potential prognostic indicators for CESC. In addition, five central genes (TP53, MMP1, NOTCH1, SMAD4, and NFKB1) were found to be directly or indirectly involved in LNM in early-stage CESC. Taken together, the results of the present study suggest that hsamiR-508, hsa-miR-509-2, and hsa-miR-526b may be potential new diagnostic and prognostic markers for CESC in the future.
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